Skip to search formSkip to main contentSkip to account menu

Indium 111In-satumomab pendetide

Known as: B72.3-GYK-DTPA, B72.3-glycyl-tyrosyl N-diethylenetriaminepentacetic acid, Indium In 111 Satumomab Pendetide 
An radioimmunoconjugate of the murine monoclonal antibody, Satumomab (MoAb B72.3), conjugated to the linker-chelator, glycyl-tyrosyl-(N… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Prostate-specific membrane antigen (PSMA) is a transmembrane protein commonly found on the surface of late-stage and metastatic… 
Review
2003
Review
2003
PURPOSE We evaluated the prognostic significance of indium-111 (111In)-capromab pendetide imaging for patients with prostate… 
Highly Cited
2002
Highly Cited
2002
Despite the ability of radical prostatectomy to eradicate prostate carcinoma, biochemical evidence of recurrent prostate… 
Review
2001
Review
2001
PURPOSE Capromab pendetide (ProstaScint) is an indium In 111 ((111)In)-labeled monoclonal antibody to prostate-specific membrane… 
Highly Cited
1999
Highly Cited
1999
Highly Cited
1999
The pretherapy prediction of occult lymph node involvement and the avoidance of otherwise futile and potentially morbid… 
Highly Cited
1998
Highly Cited
1998
PURPOSE We investigated the ability of In-111-capromab pendetide to separate patients who have failed radical prostatectomy into… 
Highly Cited
1998
Highly Cited
1998
Optimum therapy for prostate carcinoma patients requires accurate staging, but computed tomography (CT) and magnetic resonance… 
Highly Cited
1992
Highly Cited
1992
Immunoscintigraphy performed after intravenous administration of indium-111-labeled CYT-103, an immunoconjugate of monoclonal…